Strive, Inc. Variable Rate Series A Perpetual Preferred Stock（SATA）財務資料SATAStrive, Inc. Variable Rate Series A Perpetual Preferred Stock

Evaluating the bottom line, Strive, Inc. Variable Rate Series A Perpetual Preferred Stock maintains a gross margin of -454.71%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -729.51%, while the net margin is -8759.03%. These profitability ratios, combined with a Return on Equity (ROE) of -170.21%, provide a clear picture of how effectively SATA converts its operational activities into shareholder value.

Lisata Therapeutics has shown poor financial performance with a net income loss of -$4,489,000 in Q1 2026 and a year-to-date change of -47.96%. The gross margin fluctuates significantly, indicating instability in revenue generation.